Perifosine as a potential novel anti-telomerase therapy.

Item

http://www.wikidata.org/entity/Q36355806

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Perifosine as a potential novel anti-telomerase therapy.

@ast

Perifosine as a potential novel anti-telomerase therapy.

@en

type

Item

label

Perifosine as a potential novel anti-telomerase therapy.

@ast

Perifosine as a potential novel anti-telomerase therapy.

@en

prefLabel

Perifosine as a potential novel anti-telomerase therapy.

@ast

Perifosine as a potential novel anti-telomerase therapy.

@en

P1476

Perifosine as a potential novel anti-telomerase therapy.

@en

P2093

Brody Holohan

http://www.w3.org/2001/XMLSchema#string

Daphne R Friedman

http://www.w3.org/2001/XMLSchema#string

Ejun Huang

http://www.w3.org/2001/XMLSchema#string

Jerry W Shay

http://www.w3.org/2001/XMLSchema#string

Moriah M Hagiopian

http://www.w3.org/2001/XMLSchema#string

Tsung-Po Lai

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis

Specific association of human telomerase activity with immortal cells and cancer

Regulation of telomerase activity and anti-apoptotic function by protein-protein interaction and phosphorylation

Cell biology of disease: Telomeropathies: an emerging spectrum disorder

DNA damage foci at dysfunctional telomeres

A survey of telomerase activity in human cancer

Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.

A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.

Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway.

P304

21816-21826

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.5200

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Woodring E. Wright

P577

2015-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281343311

http://www.w3.org/2001/XMLSchema#string

P698

26307677

http://www.w3.org/2001/XMLSchema#string

P932

4673128

http://www.w3.org/2001/XMLSchema#string